ATE132191T1 - Auflösbare interferon-gamma-rezeptoren sowie verfahren zu deren herstellung - Google Patents

Auflösbare interferon-gamma-rezeptoren sowie verfahren zu deren herstellung

Info

Publication number
ATE132191T1
ATE132191T1 AT90106992T AT90106992T ATE132191T1 AT E132191 T1 ATE132191 T1 AT E132191T1 AT 90106992 T AT90106992 T AT 90106992T AT 90106992 T AT90106992 T AT 90106992T AT E132191 T1 ATE132191 T1 AT E132191T1
Authority
AT
Austria
Prior art keywords
gamma receptors
dissolvable
interferon
production
receptors
Prior art date
Application number
AT90106992T
Other languages
English (en)
Inventor
Michael Fountoulakis
Gianni Garotta
Dietrich Stueber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE132191T1 publication Critical patent/ATE132191T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90106992T 1989-04-19 1990-04-11 Auflösbare interferon-gamma-rezeptoren sowie verfahren zu deren herstellung ATE132191T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89810295 1989-04-19

Publications (1)

Publication Number Publication Date
ATE132191T1 true ATE132191T1 (de) 1996-01-15

Family

ID=8203144

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90106992T ATE132191T1 (de) 1989-04-19 1990-04-11 Auflösbare interferon-gamma-rezeptoren sowie verfahren zu deren herstellung

Country Status (11)

Country Link
EP (1) EP0393502B1 (de)
JP (1) JPH02303490A (de)
AT (1) ATE132191T1 (de)
AU (1) AU625866B2 (de)
CA (1) CA2014752A1 (de)
DE (1) DE69024398T2 (de)
DK (1) DK0393502T3 (de)
IE (1) IE901373L (de)
IL (1) IL94081A (de)
NZ (1) NZ233308A (de)
ZA (1) ZA902843B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88378A (en) * 1988-11-14 2000-11-21 Yeda Res & Dev Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
JPH05502037A (ja) * 1990-04-24 1993-04-15 シェリング・コーポレーション 可溶性のトランケートされたガンマ―インターフェロン受容体
WO1994012531A1 (en) * 1992-11-20 1994-06-09 Schering Corporation Antagonists of human gamma interferon
DE69322289T2 (de) 1992-12-29 1999-05-20 Genentech, Inc., South San Francisco, Calif. Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren
CA2114168A1 (en) * 1993-03-05 1994-09-06 Zlatko Dembic Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
US6045997A (en) * 1995-11-23 2000-04-04 Duke University Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
US7020843B2 (en) 1999-11-30 2006-03-28 Uhc Llc Method and system for implementing a browser object container
US6606103B1 (en) 1999-11-30 2003-08-12 Uhc Llc Infinite resolution scheme for graphical user interface object
CU23229A1 (es) * 2002-05-10 2007-09-26 Ct Ingenieria Genetica Biotech ANTAGONISTA QUIMéRICO ANTH1
US7608430B2 (en) 2005-07-08 2009-10-27 Regeneron Pharmaceuticals, Inc. Interferon-γ antagonists and therapeutic uses thereof
GB0624071D0 (en) * 2006-12-01 2007-01-10 Bioline Res Ltd Purification methods and materials
WO2025049345A1 (en) 2023-08-25 2025-03-06 Proteologix Us Inc. Anti-il-13 multispecific antibody constructs and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody

Also Published As

Publication number Publication date
EP0393502A1 (de) 1990-10-24
CA2014752A1 (en) 1990-10-19
DE69024398T2 (de) 1996-06-13
AU5309390A (en) 1990-11-08
IL94081A (en) 1996-09-12
IE901373L (en) 1990-10-19
IL94081A0 (en) 1991-01-31
DK0393502T3 (da) 1996-03-04
EP0393502B1 (de) 1995-12-27
AU625866B2 (en) 1992-07-16
NZ233308A (en) 1992-11-25
JPH02303490A (ja) 1990-12-17
DE69024398D1 (de) 1996-02-08
ZA902843B (en) 1990-12-28

Similar Documents

Publication Publication Date Title
ATE132191T1 (de) Auflösbare interferon-gamma-rezeptoren sowie verfahren zu deren herstellung
DE3777000D1 (de) Aus der gasphase hergestellter diamant, sowie verfahren zu dessen herstellung.
DE3764602D1 (de) Verfahren zur herstellung von n,n-diaryl-harnstoffen.
DE3869920D1 (de) Verfahren zur herstellung von 1,1-dichlor-1,2,2,2-tetrafluoraethan.
DE68911508D1 (de) Verfahren zur herstellung von linear ausgedehnten polyalkylenpolyaminen.
DE3769648D1 (de) Verfahren zur herstellung von kohlenstoffmolekularsieben.
DE3860671D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin.
DE3583338D1 (de) Verfahren zum herstellen von maschinenteilen aus polymerbeton sowie maschinenteile hergestellt nach diesem verfahren.
DE3779088D1 (de) Verfahren zur herstellung von alkylazide-substituierten, durch hydroxy-geendeten polyaethern.
DE3677740D1 (de) 2-iod-perfluor-2-methylalkane, verfahren zu deren herstellung und deren verwendung.
DE3579136D1 (de) Verfahren zur herstellung von hochgereinigten, hepatitis-b-virus-infektionsfreien gammaglobulinen.
DE3576817D1 (de) Verfahren zur herstellung von aminen.
DE3879673D1 (de) Verfahren zur herstellung dicker, ballistisch bestaendiger materialien.
DE3861031D1 (de) Verfahren zur herstellung von 5-amino-4,6-dihalogenpyridinen.
DE59001106D1 (de) Verfahren zur herstellung von 1,1,1-trifluor-2-chlorethan.
DE68906500D1 (de) Verfahren zur herstellung von 2,6-dimethylnaphthalin.
DE59002382D1 (de) Alkadiennitrile, verfahren zu ihrer herstellung und ihre verwendung.
DE3778329D1 (de) Verfahren zur herstellung von 2,6-dichlorobenzonitril.
DE3762619D1 (de) Verfahren zur herstellung monomerer alpha-cyanacrylate.
DE59001534D1 (de) Verfahren zur herstellung von aminen.
DE3871591D1 (de) Verfahren zur herstellung von 1-propargyl-2,4-dioxoimidazolidin.
DE68916022D1 (de) Verfahren zur herstellung von wasserstoffgas.
DE59002140D1 (de) Verfahren zur herstellung von 2,3,5-trimethyl-p-benzochinon.
ATE61584T1 (de) Verfahren zur herstellung von 2,4-diamino-3-oxy- pyrimidin-derivaten.
DE3775849D1 (de) Verfahren zur produktion von eisen-ii-sulfid.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee